Banque Pictet & Cie’s Abivax ABVX Stock Holding History

Banque Pictet & Cie’s Portfolio ABVX Stock Details ABVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-15,040	Closed	-$1.67M	–	332
2026 Q1	$1.67M	Sell	15,040 -308	-2%	-$36.5K	0.01%	234
2025 Q4	$2.07M	Buy	+15,348	New	+$1.67M	0.01%	213

Other funds holding ABVX

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Helikon Investments London, United Kingdom $3.35B AUM 55.08% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Jupiter Topco New York $245B AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Banque Pictet & Cie's ABVX Position: Q2 2026 in Review

Banque Pictet & Cie sold out of Abivax (ABVX) in Q2 2026, closing a stake of 15,040 shares — an estimated $1.67M sold.

Banque Pictet & Cie first reported a position in ABVX in Q4 2025 and held it in 2 quarters. The position peaked at $2.07M in Q4 2025. 304 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

Banque Pictet & Cie reported no remaining Abivax position as of Q2 2026 after selling out during the quarter.
Banque Pictet & Cie sold 15,040 Abivax shares in Q2 2026, an estimated $1.67M.
Banque Pictet & Cie first reported a position in Abivax in Q4 2025 and held it in 2 quarters.
Banque Pictet & Cie's Abivax position peaked at $2.07M in Q4 2025.
304 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Banque Pictet & Cie's 13F filing for Q2 2026, filed 24 Jul 2026.